When do semaglutide patents expire in 2026?
Specific “semaglutide patent expiration by country” timelines for 2026 depend on (1) which exact semaglutide product you mean (Ozempic, Wegovy, Rybelsus), (2) which patent families are being counted (active ingredient vs. formulation vs. method-of-use), and (3) each country’s rules for patent term adjustments and supplemental protection (for example, SPC/EEA-style extensions).
With only the provided information, there are no country-by-country expiration dates I can state accurately for 2026.
What you can do to get exact country dates for 2026
To produce a reliable “by country” list, you need to start from the correct patent family and then check legal status in each jurisdiction. A practical approach is:
- Identify the product and the specific active ingredient salt/base (semaglutide) and indication.
- Look up the relevant patent family in a patent register for each country.
- Apply local extension rules (SPC/extension, patent term adjustments, etc.) to reach the final “expires on” date.
Which semaglutide products most affect 2026 timelines?
People searching “semaglutide patent expiration” often mean one of these:
- Ozempic (type 2 diabetes)
- Wegovy (chronic weight management)
- Rybelsus (oral semaglutide)
Patent coverage and exclusivity differ by product and by indication, so the expiration year in one country can differ from another if you’re counting “the patent” versus “exclusivity” (regulatory/market exclusivity) versus “all related patents.”
Can you legally market semaglutide generics in 2026 even if a patent still exists?
In many cases, companies seek:
- carve-outs under patent law (for example, launching on non-infringing claims), or
- deals/settlements that allow earlier market entry, or
- challenges to specific patents (validity/enforceability), leading to different effective timelines by country.
So “patent expiration” and “first generic/alternative launch date” are often not the same thing.
Source to use for a 2026-by-country patent expiration timeline
DrugPatentWatch.com is commonly used to track patent status and timelines by geography for specific drugs and products; if you share which semaglutide product(s) you mean, it can be used to generate the country-level expiration picture you’re asking for.
You can start here: https://www.drugpatentwatch.com/ [1]
---
What I need from you to give an accurate “2026 by country” table
1) Which product: Ozempic, Wegovy, Rybelsus, or “all semaglutide products”?
2) Which countries/regions: EU5 (France/Germany/Italy/Spain/UK), US, Canada, Japan, Australia, etc.?
3) Do you want “patent expiry” dates only, or also “regulatory exclusivity” (where applicable)?
Reply with those details and I’ll turn it into a country-by-country 2026 expiration timeline.
Sources
[1] https://www.drugpatentwatch.com/